Examples
|
| Fosamax | alendronate sodium | |
| Aredia | pamidronate disodium | |
| Actonel | risedronate sodium | |
| Skelid | tiludronate disodium | |
| Reclast | zoledronic acid | |
You take alendronate, risedronate, and tiludronate by
mouth (orally). Pamidronate and zoledronic acid are given
intravenously.
How It Works
Bisphosphonates decrease the number and
activity of bone cells (osteoclasts) to reduce the breakdown of bone tissue.
Over time, they may also decrease the activity of other bone cells
(osteoblasts) that are building up too much bone.1
Bone has a more normal structure after bisphosphonate therapy.2
Why It Is Used
Bisphosphonates first decrease bone
tissue breakdown and, later, decrease overproduction of new bone tissue. This
leads to more normal bone structure, and then to decreased pain and risk of
fracture.
Doctors may use bisphosphonates to treat people with
Paget's disease who do not yet have symptoms, to help
prevent
complications. They also use bisphosphonates before
surgery to decrease the activity of Paget's disease, so there is less risk of
bleeding and complication from the surgery.
How Well It Works
Most often, bisphosphonates are the
first medicines doctors use to treat Paget's disease and control its
symptoms.
Bisphosphonates slow the rate of bone tissue breakdown
and increase bone thickness in the spine and hip. This reduces the progression
of the disease. Bisphosphonates can also decrease symptoms such as bone pain,
ringing in the ears, dizziness, and numbness or weakness that Paget's disease
can cause.
Bisphosphonates may take several months to become fully
effective. Effects of bisphosphonates tend to last even after the person stops
taking the medicine. On occasion, a person may need additional courses of the
medicine to treat a return to
active disease.
Reduction in laboratory
markers such as alkaline phosphatase shows that the medicine is working to
reduce the activity of Paget's disease. Some people eventually become resistant
to one medicine, so it doesn't work as well to control their symptoms. When
this happens, another bisphosphonate or another medicine may be
effective.2
Side Effects
Side effects of bisphosphonates can
include:
- Severe heartburn.
- Belly pain and
irritation of the throat (esophagus).
- Upset stomach
(nausea).
- Diarrhea, constipation, and increased gas.
- Flu-like symptoms including headache and pain in muscles and
joints (especially if you take intravenous medicine).
- Increased bone pain. (This tends to be related to the dose of
medicine used.)
You may limit side effects by taking the medicine on an
empty stomach and by drinking a full glass of water with the medicine. Staying
upright and not lying down for 30 minutes to 1 hour after you take this
medicine may also help limit side effects. Also, do not have any food or
beverage (other than water) for 30 minutes after you take the medicine.
Serious problems with bone healing, particularly after dental surgery,
have been found in some people taking bisphosphonates.3 If you are taking bisphosphonates and need dental surgery,
talk with your doctor about the risk of problems with bone healing.
See Drug Reference for a full list of side effects. (Drug Reference is
not available in all systems.)
What To Think About
People generally use oral
bisphosphonates for 2 to 6 months.
Alendronate, risedronate, and
tiludronate can cause damage to the throat (esophagus).1 You should not use them if you have a malfunction of the
nerves of the
esophagus (achalasia), an inflammation (esophagitis)
or narrowing (esophageal stricture) of the esophagus, or a
hiatal hernia.
You should not take these
medicines immediately before or just after meals, because food slows the
absorption of the medicine. How soon before or after a meal you take the
medicine varies with the medicine. Talk with your doctor or nurse, and follow
instructions carefully.
Take bisphosphonates with water, not milk,
because milk also decreases the absorption of the medicine.
Your
doctor or nurse may suggest that you take
calcium and
vitamin D supplements while you are taking
bisphosphonates. This can help keep your bones strong. Do not take
bisphosphonates within 2 hours of taking antacids or medicines high in calcium,
magnesium, iron, or aluminum (such as Mylanta or
Tums).
Pamidronate and zoledronic acid are given
intravenously. People who cannot take the medicine by
mouth have used these medicines successfully.
Bisphosphonates are
often used in cycles. They nearly always make Paget's disease
inactive, sometimes for years or decades. But in some
people Paget's disease becomes
active again. You use bisphosphonates until pain
decreases and lab tests show normal results. Then you take a break from the
medicine for about 3 months, or until lab tests show that Paget's disease is
active again.4
Bisphosphonates are better
than calcitonin for slowing or eliminating disease activity.2
Complete the new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
Favus MJ, Vokes TJ (2005). Paget disease and other
dysplasias of bone. In DL Kasper et al., eds., Harrison's Principles of Internal Medicine, 16th ed., vol. 2, pp. 2279-2286. New
York: McGraw-Hill.
Altman RD (2005). Paget's disease of bone. In WJ
Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 2543-2557. Philadelphia:
Lippincott Williams and Wilkins.
Woo S-B, et al. (2006). Systematic review: Bisphosphonates and osteonecrosis of the jaw. Annals of Internal Medicine, 144(10): 753-761.
Fitzgerald PA (2007). Paget's disease of bone
(Osteitis deformans) section of Endocrinology. In LM Tierney et al., eds.,
Current Medical Diagnosis and Treatment, 46th ed., pp.
1186-1187. New York: McGraw-Hill.
Credits
| Author | Shannon Erstad, MBA/MPH |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | Matthew I. Kim, MD - Endocrinology & Metabolism |
| Last Updated | September 14, 2007 |
Favus MJ, Vokes TJ (2005). Paget disease and other
dysplasias of bone. In DL Kasper et al., eds., Harrison's Principles of Internal Medicine, 16th ed., vol. 2, pp. 2279-2286. New
York: McGraw-Hill.
Altman RD (2005). Paget's disease of bone. In WJ
Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 2543-2557. Philadelphia:
Lippincott Williams and Wilkins.
Woo S-B, et al. (2006). Systematic review: Bisphosphonates and osteonecrosis of the jaw. Annals of Internal Medicine, 144(10): 753-761.
Fitzgerald PA (2007). Paget's disease of bone
(Osteitis deformans) section of Endocrinology. In LM Tierney et al., eds.,
Current Medical Diagnosis and Treatment, 46th ed., pp.
1186-1187. New York: McGraw-Hill.